Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
The podcast can be downloaded here and is embedded below. Subscribe to the podcast via Apple Podcast, Google Play, Spotify or the RSS feed. Updates on the podcast on Twitter at @Lawbytespod.
Credits:
CTV News, Canada’s Chief Public Health Officer Says a Coronavirus Vaccine is ‘Probably’ a Year Away
AI Minister Evan Solomon’s AI public consultation – framed as a 30 day sprint – wrapped up last week with expectations that the government...
Is the Canadian media in a state of financial crisis? Stories on newspaper closures and journalist layoffs have become frustratingly commonplace in recent years,...
Canadian digital law and policy in 2025 was marked by the unpredictable with changes in leadership in Canada and the U.S. driving a shift...